On 30 June 2017, Dr. Piyush Gupta of GNH shared his views on Times Now's News Hour about how the pharmaceutical industry was preparing for the rollout of India's Goods and Services Tax (GST).
GST is India's unified indirect tax, which replaced a range of earlier central and state taxes and came into effect on 1 July 2017. The transition represented a significant change for manufacturers, distributors, and suppliers across the pharmaceutical sector, affecting pricing, supply-chain logistics, and compliance processes. In the segment, Dr. Gupta discussed, at a high level, how the industry was readying itself for the new tax regime ahead of its implementation.
As a worldwide pharmaceutical distributor, GNH USA works across international supply chains and regulatory environments, supporting clients with comparator sourcing, named-patient supply, and reliable global distribution.